Latest Regulatory News

GBM Resources has reported exceptional high-grade gold intersections more than 100 metres outside its existing 309 deposit resource at Twin Hills, Queensland, signalling promising potential for resource expansion.

Nova Eye Medical has reported a record US$6.1 million in global sales for the December 2025 quarter, marking a 38% year-on-year increase and strong momentum across key markets. The company’s innovative iTrack™ technology continues to drive growth, supported by expanded manufacturing capacity and advancing clinical programs.

NGX Limited has progressed its natural graphite exploration in Malawi and uranium projects in Namibia, while maintaining a robust financial footing with $2.7 million cash and no debt. The company is actively pursuing strategic partnerships and development pathways aligned with the clean energy transition.

Whitehaven Coal reported a strong December quarter with a 21% rise in production and improved metallurgical coal prices, underpinning a solid first half of FY26. The company also advanced key development projects while maintaining disciplined cost management.

Imricor Medical Systems has achieved a major milestone with FDA clearance for its NorthStar Mapping System, the first MRI-native 3D cardiac mapping platform approved in the US. This approval positions Imricor at the forefront of MRI-guided cardiac procedures in the world’s largest electrophysiology market.

NOVONIX is ramping up industrial-grade synthetic graphite production with mass manufacturing slated for 2026, while battery-grade output for Panasonic faces delays until late 2027. The company also navigates a major offtake termination and secures significant funding to support its growth.

Maronan Metals has secured crucial environmental approvals and completed promising drilling and metallurgical work, underpinned by a strong capital raise and rising silver prices.

Native Mineral Resources has kicked off 2026 with a record 1,475 oz gold pour at its Blackjack Gold Operations, signalling strong momentum and operational progress in Queensland.

Cleo Diagnostics has broadened its U.S. market opportunity to around 2 million women annually and is on track to complete its pivotal clinical trial early this year, supported by a $5 million capital raise and regulatory progress.

Macquarie Asset Management has extended the exclusivity period for its proposed transaction with Qube Holdings, signalling ongoing progress yet leaving the final outcome uncertain.

Osmond Resources has reported exceptional initial drilling results from its Orión EU Critical Minerals Project in Spain, advancing towards a maiden Mineral Resource Estimate and Scoping Study in 2026. A recent $6.6 million placement boosts the company’s cash position to over $8.5 million, underpinning further development.

MyEco Group Ltd has reported record quarterly sales of its MyEcoBag® products, alongside improved gross margins and a significant reduction in operating cash outflows following a strategic operational restructure.